Cite
MLA Citation
Rashmi Kumari et al.. “Complete Response to Afatinib in Lung Adenocarcinoma of Epidermal Growth Factor Receptor Exon-19 Deletion Mutation and Disease Recurrence on Drug Discontinuation.” Journal of pharmacology and pharmacotherapeutics, vol. 9, no. 4, 2018, pp. 191–194. http://access.bl.uk/ark:/81055/vdc_100147183145.0x000009